Advertisement
Surgery
Subscribe to Surgery
View Sample

FREE Email Newsletter

China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.'s Sales Forecast in Excess of $10,000,000

August 16, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., Aug. 16, 2011 /- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine, Inc. ("SurgLine") and one of its previously announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the final stages of completing a multi-million dollar...

Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System

August 16, 2011 6:46 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Aug. 16, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced today that the Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School and a leader in pioneering innovative technology to...

Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference

August 12, 2011 4:46 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Aug. 12, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals, is scheduled to present at the Wedbush Securities 2011 Life...

Advertisement

Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results

August 11, 2011 3:47 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Aug. 11, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced financial results for the second quarter ended June 30, 2011, provided an update on the execution of its pre-commercial and launch strategies for...

Cook Medical's Doppler Blood Flow Monitor a Significant Advance for Free Flap Procedures

August 10, 2011 10:47 am | News | Comments

Technology leverages company's patented Doppler platform, providing surgeons with a direct vessel monitoring tool to assist in transplant and reconstructive surgeries

Patent Granted for Simbionix Procedure Rehearsal Studioâ„¢

August 10, 2011 7:45 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Ohio, August 10, 2011 /- Simbionix USA Corporation, the world's leading provider of medical simulation training and education products for medical professionals and the healthcare industry, is pleased to announce it has been granted a patent in the UK for its innovative...

Misonix Announces Entry Into Surgical Wound Debridement

August 10, 2011 7:45 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 10, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

August 9, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others...

Advertisement

MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device

August 9, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 9, 2011 /- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced its new DynaNail™ Intramedullary Ankle Fusion Nail. Ankle fusion is performed to relieve pain in patients with severely degenerative ankle joints, to...

David J. Illingworth Appointed to Board of Directors for Varian Medical Systems

August 5, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Aug. 5, 2011 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that David J. Illingworth, a former CEO and member of the Board of Directors for Smith & Nephew and veteran of more than 30 years of management in global medical device businesses, has been...

Misonix Announces Update of Product Registration in Brazil

August 5, 2011 5:41 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 5, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

Precision Optics lands $2.5M in patent sale

August 4, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Precision Optics Corp. Inc., a maker of advanced optical instruments in Gardner, has formed a deal with Intuitive Surgical Operations Inc., a surgical robotics firm in California, bringing $2.5 million to Precision Optics.

Hanger Orthopedic Group Announces Five Acquisitions Producing $20.2 million of Annual Net Revenue

August 3, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Aug. 3, 2011 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) is pleased to announce the acquisition of Team Post-Op, Inc., BioConcepts, Inc., US Orthotics & Prosthetics, Inc., MK Prosthetic & Orthotic Services, Inc, and Rainier Surgical Incorporated &...

Advertisement

Misonix Announces New Distribution Agreement for Taiwan

August 3, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 3, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

Cantel Medical Acquires Byrne Medical, Inc., Substantially Increasing Its Presence in GI Endoscopy

August 2, 2011 6:48 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Aug. 2, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ), through its Minntech subsidiary, has acquired the business and substantially all of the assets of Byrne Medical, Inc.  Byrne Medical, privately-owned and based outside Houston, TX, designs, manufactures and sells...

MedSolutions Introduces Spine Surgery Management Program

July 21, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Tenn., July 21, 2011 /- MedSolutions , a leading provider of medical management services, today announced the launch of its Lumbar Spine Surgery Management Program for ensuring the clinical appropriateness of spine surgery for individuals suffering from lower back pain, spinal...

Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESSâ„¢ 30 Surgical Cutting and Stapling Device

July 19, 2011 10:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., July 19, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Andreas Kuthe, M.D., Chief of General Surgery at the Red Cross Hospital Clementinenhaus, Hannover, Germany, successfully completed a total of five laparoscopic procedures using Cardica's' proprietary...

Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing

July 19, 2011 1:42 am | by Bio-Medicine.Org | News | Comments

ZURICH, July 19, 2011 /-   Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S....

Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

July 18, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, July 18, 2011 /- Shire plc (LSE: SHP; NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients...

Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis

July 18, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, July 18, 2011 /-   Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda ® (mesalamine) Delayed Release Tablets for the maintenance of remission in...

Hologic to Participate in Four Investor Conferences

July 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., July 14, 2011 /- Hologic, Inc. (NASDAQ: HOLX ) today announced that company management will participate in the following conferences: Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in...

FDA: Surgical Placement of Mesh to Repair Pelvic Organ Prolapse Poses Risks

July 13, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 13, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today issued an updated safety communication warning health care providers and patients that surgical placement of mesh through the vagina to repair pelvic organ prolapse may expose patients...

Stryker Ends Distribution Agreement With Corin PLC

July 13, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J., July 13, 2011 /- Stryker Corporation's Orthopaedics division has reached a mutual agreement with Corin PLC in which Corin will resume direct distribution of the Cormet Hip Resurfacing System. Stryker will no longer act as a distributor of the product. "Distribution of a hip...

MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015

June 30, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, Texas, June 30, 2011 /- The ' Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015) " analyzes the lung cancer market by types of surgical procedures and surgical devices and studies the market dynamics of North America, Europe and...

Boston Scientific Welcomes Publication of Landmark Report on Chronic Pain

June 30, 2011 8:36 am | by Boston Scientific | News | Comments

NATICK, Mass., June 30, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of Sciences titled Relieving

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading